Physician profile
Jerry B Jarrell
NPI 1194717975
$2,265.49
in general payments reported to CMS, 2019-2025
16 companies · $22.23 in 2025
The $22.23 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $196 · 2021: $348 · 2022: $237 · 2023: $307 · 2024: $248 · 2025: $22.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $689.89 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $391.80 | 2019-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $255.46 | 2019-2023 | Breztri |
| Amgen INC. | $237.77 | 2019-2024 | Repatha, Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $150.19 | 2022-2024 | |
| Lilly USA, LLC | $129.10 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $114.70 | 2023-2025 | |
| Biogen, INC. | $101.66 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.09 | 2019 | |
| Boston Scientific Corporation | $26.67 | 2024 | Vercise |
| Otsuka America Pharmaceutical, INC. | $25.94 | 2024 | Rexulti |
| Sanofi Pasteur INC. | $19.06 | 2023 | |
| Pfizer INC. | $16.18 | 2024 | |
| Radius Health, INC. | $14.85 | 2019 | |
| Corium, LLC | $14.76 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Jarrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.